Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Programming obesity in childhood

David S Ludwig1, Steven L Gortmaker

  • 1Department of Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA. david.ludwig@childrens.harvard.edu

Lancet (London, England)
|July 21, 2004
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Night-to-Night Sleep Duration and Wake-Anchored Glycaemia: Associations with Continuous Glucose Monitoring in Free-Living Adolescents.

Sleep·2026
Same author

Is the experimental evidence on ultra-processed food and obesity reliable?

Critical reviews in food science and nutrition·2026
Same author

Patient, family and provider experiences with a very low-carbohydrate approach for type 1 diabetes.

Journal of metabolic health·2026
Same author

Are ultra-processed foods too tasty? Toward a metabolic framework for diet and obesity.

PLoS medicine·2026
Same author

Ultra-processed foods in research and policy.

Lancet (London, England)·2026
Same author

Overcoming impasse in nutrition science.

Cell metabolism·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles